Ping An Healthcare and Technology Company Limited (HK:1833)
:1833
Want to see HK:1833 full AI Analyst Report?
Top Page
Ping An Healthcare and Technology Company
(1833)
Select Model
Select Model
Rating:55Neutral
Price Target:
HK$9.00
▼(-25.31% Downside)
Action:Reiterated
Date:03/27/26
The score is mainly supported by improving profitability and cash flow with very low leverage, but is held back by weak technical trend signals (price below all key moving averages and negative MACD) and a high P/E without dividend yield support.
Positive Factors
Low Leverage
Extremely low debt-to-equity provides durable financial flexibility for a healthcare platform, reducing insolvency risk and enabling steady investment in technology, partnerships, or M&A. This conservative capital structure supports long-term strategy through cycles and limits interest burden on cash generation.
Negative Factors
Revenue Volatility
Sharp top-line swings reduce predictability of marketplace growth for a digital healthcare platform and can mask durability of customer demand. Inconsistent revenue trends complicate capacity planning, margin sustainability, and the ability to forecast returns on long-term investments in products and partnerships.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage
Extremely low debt-to-equity provides durable financial flexibility for a healthcare platform, reducing insolvency risk and enabling steady investment in technology, partnerships, or M&A. This conservative capital structure supports long-term strategy through cycles and limits interest burden on cash generation.
Read all positive factors
Ping An Healthcare and Technology Company (1833) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$19.06B
Dividend YieldN/A
Average Volume (3M)17.30M
Price to Earnings (P/E)45.0
Beta (1Y)1.24
Revenue Growth13.84%
EPS Growth146.34%
CountryHK
Employees1,563
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)0.18
Shares Outstanding2,161,443,600
10 Day Avg. Volume8,945,339
30 Day Avg. Volume17,297,252
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)2.69
Price to Sales (P/S)4.88
P/FCF Ratio68.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$16.56Price Target Upside37.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
EPS Forecast (FY)0.22
Revenue Forecast (FY)HK$5.95B
Ping An Healthcare and Technology Company Business Overview & Revenue Model
Company Description
Ping An Healthcare and Technology Company Limited, together with its subsidiaries, operates an online healthcare services platform in the People's Republic of China. It offers online medical services, such as online consultation, hospital referral...
How the Company Makes Money
null...
Ping An Healthcare and Technology Company Financial Statement Overview
Summary
Income Statement
63
Positive
Balance Sheet
82
Very Positive
Cash Flow
60
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.47B | 4.81B | 4.67B | 6.21B | 7.33B |
| Gross Profit | 1.77B | 1.52B | 1.51B | 1.67B | 1.71B |
| EBITDA | 238.67M | 193.43M | -164.23M | -1.05B | -1.76B |
| Net Income | 379.51M | 81.43M | -322.59M | -636.06M | -1.54B |
Balance Sheet | |||||
| Total Assets | 13.24B | 16.78B | 16.52B | 17.14B | 17.88B |
| Cash, Cash Equivalents and Short-Term Investments | 6.97B | 11.52B | 11.35B | 10.14B | 10.14B |
| Total Debt | 39.81M | 45.00M | 93.61M | 176.49M | 201.29M |
| Total Liabilities | 3.33B | 13.20B | 3.25B | 3.68B | 3.79B |
| Stockholders Equity | 9.92B | 3.59B | 13.28B | 13.46B | 14.08B |
Cash Flow | |||||
| Free Cash Flow | 391.83M | 65.08M | -325.82M | -845.05M | -1.49B |
| Operating Cash Flow | 430.72M | 99.33M | -282.86M | -810.62M | -1.40B |
| Investing Cash Flow | 3.04B | 114.65M | -1.49B | 1.71B | -3.10B |
| Financing Cash Flow | -3.84B | -38.44M | -67.36M | -317.88M | -319.91M |
Ping An Healthcare and Technology Company Technical Analysis
Negative
12.05
Price Trends
10.84
Negative
12.49
Negative
14.53
Negative
Market Momentum
-0.61
Negative
30.00
Positive
30.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1833, the sentiment is Negative. The current price of 12.05 is above the 20-day moving average (MA) of 9.63, above the 50-day MA of 10.84, and below the 200-day MA of 14.53, indicating a bearish trend. The MACD of -0.61 indicates Negative momentum. The RSI at 30.00 is Positive, neither overbought nor oversold. The STOCH value of 30.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1833.
Ping An Healthcare and Technology Company Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$5.51B | 14.03 | 6.83% | 2.72% | 15.04% | 5.57% | |
66 Neutral | HK$1.46B | 9.12 | 39.78% | 9.92% | -23.31% | -44.61% | |
62 Neutral | HK$1.02B | -19.43 | -2.95% | ― | 4.75% | 87.06% | |
55 Neutral | HK$19.06B | 44.99 | 3.83% | ― | 13.84% | 146.34% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
45 Neutral | HK$5.52B | -52.68 | -2.28% | ― | -4.99% | 47.18% |
* Healthcare Sector Average
HK:1833
Ping An Healthcare and Technology Company
8.76
1.92
28.07%
HK:9886
Dingdang Health Technology Group Ltd.
0.85
0.29
51.79%
HK:1830
Perfect Medical Health Management Limited
1.16
-0.98
-45.79%
HK:2158
Yidu Tech, Inc.
5.12
-1.39
-21.35%
HK:2192
Medlive Technology Co., Ltd.
7.41
-6.58
-47.05%
HK:2506
Xunfei Healthcare Technology Co., Ltd.
83.90
-37.10
-30.66%
Ping An Healthcare and Technology Company Corporate Events
Ping An Healthcare Shifts Hong Kong Office and Appoints New Process Agent
Apr 23, 2026
Ping An Healthcare and Technology Company Limited has relocated its principal place of business in Hong Kong to the 40th Floor of Dah Sing Financial Centre in Wanchai, effective 23 April 2026. The move may reflect ongoing operational adjustments a...
Ping An Healthcare Delivers Strong Q1 2026 Profit Growth on Insurance Synergy and AI-Driven Health Services
Apr 23, 2026
Ping An Healthcare and Technology Company reported first-quarter 2026 revenue of RMB1.16 billion, up 9.1% year on year, with net profit more than doubling to RMB79.1 million and adjusted net profit rising 45.8% to RMB84.4 million. Management attri...
Ping An Healthcare Shareholders Approve All AGM Resolutions, Renew Capital Mandates
Apr 23, 2026
Ping An Healthcare and Technology Company shareholders approved all resolutions at the 23 April 2026 annual general meeting in Shanghai, with approximately 59.7% of issued shares represented in person or by proxy. The meeting endorsed the 2025 aud...
Ping An Healthcare and Technology Sets Board Meeting to Approve Q1 2026 Results
Apr 10, 2026
Ping An Healthcare and Technology Company has scheduled a board meeting for 23 April 2026 to review, approve and publish the group’s first-quarter results for the period ended 31 March 2026. The meeting will also address any additional board...
Ping An Healthcare sets 2026 AGM to renew board, auditor and share issuance mandate
Mar 30, 2026
Ping An Healthcare and Technology Company Limited has convened its annual general meeting for 23 April 2026 in Shanghai, where shareholders will review the audited consolidated financial statements for the year ended 31 December 2025 and consider ...
Ping An Healthcare and Technology Publishes 2025 Audited Annual Results
Mar 24, 2026
Ping An Healthcare and Technology Company Limited has released its audited annual results for the year ended 31 December 2025, fulfilling Hong Kong listing disclosure requirements with a full annual report that includes financial statements, manag...
Ping An Healthcare Sets RMB8.99 Million Cap on 2026 Intra-Group Services Deal
Mar 24, 2026
Ping An Healthcare and Technology’s wholly owned subsidiary Kang Jian has signed a 2026 services purchasing agreement with controlling shareholder Ping An, under which Ping An will continue providing financial, administrative, risk consultin...
Ping An Healthcare Reshapes Board Secretariat With New Company Secretary
Mar 24, 2026
Ping An Healthcare and Technology Company has announced a change in key governance roles, with Cheng Liu stepping down as secretary of the Board, company secretary and authorised representative due to personal work arrangements, effective 24 March...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.